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Abstract
Rheumatoid arthritis and periodontitis are two prevalent chronic inflammatory diseases in humans and are associated with
each other both clinically and epidemiologically. Recent findings suggest a causative link between periodontal infection and
rheumatoid arthritis via bacteria-dependent induction of a pathogenic autoimmune response to citrullinated epitopes. Here
we showed that infection with viable periodontal pathogen Porphyromonas gingivalis strain W83 exacerbated collagen-
induced arthritis (CIA) in a mouse model, as manifested by earlier onset, accelerated progression and enhanced severity of
the disease, including significantly increased bone and cartilage destruction. The ability of P. gingivalis to augment CIA was
dependent on the expression of a unique P. gingivalis peptidylarginine deiminase (PPAD), which converts arginine residues
in proteins to citrulline. Infection with wild type P. gingivalis was responsible for significantly increased levels of
autoantibodies to collagen type II and citrullinated epitopes as a PPAD-null mutant did not elicit similar host response. High
level of citrullinated proteins was also detected at the site of infection with wild-type P. gingivalis. Together, these results
suggest bacterial PAD as the mechanistic link between P. gingivalis periodontal infection and rheumatoid arthritis.
Citation: Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, et al. (2013) Porphyromonas gingivalis Facilitates the Development and Progression of
Destructive Arthritis through Its Unique Bacterial Peptidylarginine Deiminase (PAD). PLoS Pathog 9(9): e1003627. doi:10.1371/journal.ppat.1003627
Editor: Barbara I. Kazmierczak, Yale University, United States of America
Received March 19, 2013; Accepted July 31, 2013; Published September 12, 2013
Copyright:  2013 Maresz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
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Introduction
Rheumatoid arthritis (RA) and periodontal disease (PD) are two
common chronic inflammatory diseases affecting humans with
considerable consequences for public health and for the quality of
life of affected individuals [1]. In the case of PD, inflammation is
initiated and perpetuated by a subset of bacteria, including
Porphyromonas gingivalis, which colonize the gingival sulcus and
proliferate in the subgingival plaque. The resulting chronic
inflammatory response by the host cause eventual destruction of
the supporting structures of the teeth, leading to loss of the
dentition in severe PD. In contrast, rheumatoid arthritis is an
autoimmune disease with subsequent chronic inflammation
responsible for bone and cartilage destruction within the joints
[2,3]. Antibodies against citrullinated proteins are known to be a
specific marker that can be detected years before the onset of the
disease and their presence and serum levels correlate strongly with
disease severity. Protein citrullination is carried out by endogenous
peptidyl-arginine deiminases (PADs). These enzymes catalyze the
conversion of peptidyl-arginine to peptidyl-citrulline, which is
essential for many physiological processes [4]. However, PAD-
catalyzed protein citrullination also occurs under pathological
inflammatory conditions like necrosis and has been linked to the
breakdown of immune tolerance to citrullinated proteins leading
to induction of RA in susceptible individuals [5,6].
Although RA and PD differ in terms of their etiological
mechanisms, a link between both diseases has been established in
numerous clinical and epidemiological studies [7]. Specifically,
PLOS Pathogens | www.plospathogens.org 1 September 2013 | Volume 9 | Issue 9 | e1003627
compared to the general population, individuals with PD have an
increased prevalence of RA and, conversely, PD is at least 2-fold
more prevalent in RA patients [8]. Moreover, the clinical outcome
of PD in RA patients is more severe than in non-RA individuals
and is independent of age, gender, ethnicity, or smoking habits.
Finally, therapeutic treatment of one disease ameliorates the signs
and symptoms of the other [9,10].
The non-causal character of the PD-RA association may be due
to shared genetic and environmental risk factors, such as MHC
class II HLA-DRB1 epitope and smoking, respectively [8].
Furthermore, the two diseases have common effector destructive
mechanisms, including a similar set of effector inflammatory cells,
proinflammatory cytokines, and other mediators that drive bone
erosion. Recent findings indicate that infection with P. gingivalis
precedes RA and that the bacterium is a likely factor in the
initiation and maintenance of the autoimmune inflammatory
responses that occur in this disease [11,12]. In this respect,
presence of P. gingivalis PAD (PPAD), an enzyme expressed by P.
gingivalis but absent in other prokaryotes [13], may have a
profound impact on the development and progression of RA via
citrullination of proteins to generates neo-epitopes as hypothesized
in several recent reviews [14–16]. This novel hypothesis was tested
in the present work, in which the pathogenic outcome of collagen-
induced arthritis (CIA) was investigated in mice infected with P.
gingivalis wild-type or PAD-null isogenic strains.
Results
Impact of P. gingivalis infection on collagen-induced
arthritis development
To document that P. gingivalis can impact on the initiation, rate
of progression, and severity of arthritis we have adopted the CIA
model to quantify the contribution of infection with P. gingivalis in
the disease process. Because of DBA/1 mice resistance to oral
colonization by P. gingivalis we have employed the chamber model
of infection [17]. To this end, sterile titanium wire coils were
surgically implanted subcutaneously into mice. As part of the
healing process, the coils were subsequently encased by fibrous
tissues and the resultant hollow interior of the chambers became
suitable for inoculation of live P. gingivalis. The open architecture of
the wire chamber allows for a normal host immune response
including immune cell infiltrates. The inoculum of 108 CFU was
selected on results of preliminary experiments to sustain an
infection inside the chamber without systemic dissemination of
bacteria. At specific time points, chamber contents were sampled
via needle aspiration to assay for myeloperoxidase activity, level of
protein citrullination and to confirm the presence of live bacteria.
29 days after subsequent collagen type II (CII) immunization, all
animals inoculated with P. gingivalis wild-type strain W83 showed
clinical signs of arthritis compared to only 28% of the control
animals (p = 0.001, Fig. 1A). Mice infected with P. gingivalis had
significantly increased severity of arthritis throughout the exper-
iment (p,0.001 Fig. 1B, E, F) as compared to control (Fig. 1B, C,
D). Histological evaluation at the end of the experimental period
confirmed that P. gingivalis infection led to a 1.75-fold increase in
synovitis (arthritis index 2.4460.21, p,0.001). Moreover, bone
and cartilage erosion was 1.76-fold higher (arthritis index
2.2660.23, p,0.001) than in the CIA controls (synovitis
1.6760.17 and erosions 1.2860.23 respectively)(data not shown).
By contrast, there were no significant differences in weight change
and general health between control and infected animals.
Myeloperoxidase (MPO) activity, reflecting the number of
infiltrating neutrophils, was determined in the joints of both
groups of mice at day 45 of the experiment. Protein extracts from
the excised joints showed significantly higher MPO levels in
animals inoculated with P. gingivalis before CII immunization than
in controls (p,0.001, Fig. 1G). The massive neutrophil influx at
the sites of inflammation correlated with clinical observations of
swelling and erythema.
CIA augmentation is a feature of infection with live P.
gingivalis
Interestingly, inoculation with heat-killed P. gingivalis did not
affect either the rate or severity of CIA development suggesting a
simple bacterial antigenic challenge is insufficient for the initiation
of autoantibody production (Fig. 2A). Likewise, immunization with
P. gingivalis cell-envelope fraction which is highly citrullinated [18]
did not aggravate CIA development (Fig. 2B). Further, to
investigate the possibility that infection with any periodontal
pathogen will induce development of CIA, a second pathogen
frequently associated with periodontal disease, Prevotella intermedia,
was used as the infectious agent. Being considered as a secondary
periodontopathogen [19] this gram-negative anaerobic bacterium
is frequently found together with P. gingivalis in subgingival plaque
[20], is associated with higher risk of coronary heart disease [21],
has the ability to induce production of prostaglandin E2 which
may contribute to bone resorption in RA and PD [22], and uses
proteolytic enzymes (alike P. gingivalis) as main virulence factors
[23,24]. Moreover, P. intermedia-derived LPS stimulates strong
proinflammatory reaction [25] and bacterium-derived DNA is
frequently detected in synovial fluid of RA patients [26]. In the
CIA mouse model, however, P. intermedia failed to cause
aggravation of arthritis as compared to controls in which the
mean clinical score at the end of experiment was 8.21 (combined
score 57.5) and 9.28 (combined score 65), respectively (Fig. 2C).
This is in contrast with P. gingivalis W83 inoculated mice which
developed arthritis significantly earlier, with a higher prevalence
and reaching a plateau clinical score at 12.86 (combined score 90)
on day 40 (p,0.0001, Fig. 2C). Significantly there was no
difference in bacterial survival in chambers and both live P.
gingivalis and P. intermedia were detected in chamber fluid up to fifth
day post-inoculation (data not shown). Taken together, these
Author Summary
Clinical and epidemiological data indicates that chronic
periodontal disease (PD), one of the most prevalent
infectious inflammatory disease of mankind, is linked to
systemic inflammatory diseases such as cardiovascular
diseases (CVD), rheumatoid arthritis (RA) and chronic
obstructive pulmonary disease (COPD). Nevertheless, the
causative mechanisms of association between PD and
chronic inflammatory diseases are very poorly understood.
Recent findings suggest a causative link between peri-
odontal infection and rheumatoid arthritis via bacteria-
dependent induction of a pathogenic response to
citrullinated epitopes. In present study we show that
infection with viable periodontal pathogen Porphyromonas
gingivalis but not another oral bacterium (Prevotella
intermedia), exacerbated CIA, as manifested by earlier
onset, accelerated progression and enhanced severity of
the disease, including significantly increased bone and
cartilage destruction. The ability of P. gingivalis to augment
CIA was dependent on the expression of a unique enzyme
peptidylarginine deiminase, which converts arginine resi-
dues in proteins to citrulline. This knowledge may create
new perspectives in the treatment and prevention of RA in
susceptible individuals.
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results clearly demonstrate that exacerbation of CIA is specific to
infection with viable P. gingivalis.
Impact of P. gingivalis PAD (PPAD) on CIA development
Considering the central role of citrullinated epitopes in the
pathogenesis of RA, we investigated whether PPAD expression
contributes to the enhancement of CIA by P. gingivalis infection.
Towards this aim, an isogenic PPAD-knockout strain (dPAD) was
used to inoculate the chambers prior to CII immunization. Again,
no significant difference in survival of the dPAD mutant within the
chamber in comparison to the parental P. gingivalis strain was
observed. Nevertheless, on day 28 when, all mice inoculated with
the wild-type W83 strain demonstrated clinical symptoms of
arthritis, only 30% of the dPAD-infected animals were symptom-
atic (p = 0.002, Fig. 3A). In fact, the incidence of arthritis in dPAD
mice was the same as in the CIA controls throughout the
experiment (Fig. 3A, B). Histologically, signs of synovitis and
erosions in dPAD mice were consistently similar to CIA controls
(Fig.3 E, G), in contrast to heavy infiltrates observed in the W83
infected animals (Fig. 3F). Synovitis in the dPAD group (arthritis
Figure 1. P. gingivalis exacerbation of CIA in DBA/1 mice. Mice (n = 7) were inoculated with 16108 P. gingivalis strain W83 cells and
subsequently immunized with CII. (A) Kaplan-Meier plots showing differences in the clinical onset of arthritis (log-rank test, p,0.001) (n = 7). (B)
Mean severity of arthritis in mice followed for 5–6 weeks after immunization. Two-way ANOVA with Bonferroni’s post-test was used for the statistical
evaluation. (n = 7). (C) H&E staining of the representative inflamed tarsal joints from CII- immunized DBA/1, and (F) mice infected with wild-type P.
gingivalis strain W83 (D) Representative picture of the inflamed lower paw in CIA and (E) CIA after infection with wild type P. gingivalis. (G) Scatter dot
plot showing MPO activity in 1 g of joint tissue extract prepared at day 45 after CII immunization. Horizontal bar and error bars represent the mean
and SEM, respectively. Differences between groups were analyzed using Mann-Whitney U test (n = 20). *** denotes p,0.001.
doi:10.1371/journal.ppat.1003627.g001
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index: 0.8360.19) was less than half of the W83 infected group
(arthritis index: 2.4360.21). The extent of bone and cartilage
erosion in dPAD-infected animals (arthritis index: 0.5860.19) was
approximately one-quarter of those seen in the W83 group
(arthritis index: 2.2660.24) (Fig. 3C, 3D). Neutrophil infiltration
quantity as estimated by MPO activity in joint tissues, was also
significantly lower in the dPAD group (p,0.001, Fig. 3E).
Complementation of the PPAD gene back into the dPAD strain
(dPAD+) restored the ability of these bacteria to enhance arthritis
development (p,0.01, Fig. 4A). This confirmed that PPAD is
crucial for both the early development of CIA and the
exacerbation of arthritis symptoms.
Finally, given the role of autoantibody production in the
pathophysiology of CIA, we examined the ability of P. gingivalis
infection to influence serum levels of specific anti-CII antibodies.
In mice inoculated with W83, the serum levels of specific IgG
against CII were significantly higher than in either dPAD or CIA
control mice (p,0.05, Fig. 4B). Collectively, these data are
consistent with the clinical and morphological findings and argue
that the exacerbation of CIA by P. gingivalis infection is dependent
on PPAD expression, which appears to stimulate autoantibody
production.
Effect of P. gingivalis on host protein citrullination levels
Since the autoimmune response to citrullinated proteins has
been reported to have a significant impact on the development
and progression of RA in experimental autoimmune models [17],
both the chamber fluid and the serum of mice inoculated with P.
gingivalis were assayed for the presence of citrullinated proteins and
for antibodies specific to citrullinated epitopes, respectively. Using
Western blot, citrullinated proteins were detected exclusively in
the chamber fluid of animals inoculated with wild-type P. gingivalis
and the intensity of citrullination was proportional to the inoculum
dosage (Fig. 5A). In control animals injected with culture broth,
neither the chamber fluid nor the sera contained citrullinated
proteins. However, when the level of citrulline was determined by
a colorimetric method, some citrullination was also detected in
chambers inoculated dPAD but at lower levels than in mice
infected with wild-type bacteria (Fig. 5B). This result shows that
host PADs also contribute to citrullination but only at low levels in
this model.
Since all attempts to directly detect citrullinated mouse
fibrinogen in chamber fluid and serum by the Western blot using
specific antibodies gave negative results (data not shown), we
sought instead to detect the presence of antibodies reactive to
citrullinated epitopes. To this end, we chose to measure the level of
antibodies to citrullinated peptides (aCCP) and to specific enolase-
derived citrullinated epitope (CEP-1) implicated in autoimmunity
in RA [11]. In comparison to CIA control mice or CIA mice
infected with dPAD mutant, there was a clear increase in the level
of antibodies against CEP-1 in CIA mice infected with wild-type P.
gingivalis (Fig. 5D). Although this increase was not statistically
significant, the observed trend corroborates with a significantly
higher serum level (1.9-fold) of antibodies to citrullinated peptides
(aCCP) in mice inoculated with W83 as compared to either dPAD-
infected or CIA control mice (p,0.05 Fig. 5C). This result suggests
that P. gingivalis-induced protein citrullination within the chamber
was related to the systemic humoral immune response to CIA
within the joints.
Recently, we have found anti-PPAD antibody response is
unique for RA patients suggesting that PPAD may constitute a
neo-antigen in RA [27]. To assess if a similar immune response
was elicited in mice infected with P. gingivalis we measured serum
anti-PPAD antibody level using ELISA. In line with findings in
RA patients, mice inoculated with wild-type P. gingivalis showed the
presence of anti-PPAD antibodies but they were found at very low
level (Fig. S1) making discussion about their importance for CIA
aggravation speculative at this stage.
Discussion
Across millennia, oral health status, as evaluated by tooth decay,
has been a prognostic indicator of general health in humans. As early
as 400 BC, Hippocrates noted the association with ‘rheumatism’ by
Figure 2. Aggravation of collagen-induced arthritis was
specific to exposure to viable P. gingivalis. (A) Development of
CIA at 5–6 weeks in DBA/1 mice (n = 7) were compared after exposure
to viable P. gingivalis and heat-killed P. gingivalis; (B) Mice were
immunized with P. gingivalis cell-envelope fractions (n = 10) 3 weeks
prior to CII challenge and the development CIA were monitored at the
5–6 weeks period. (C) Mice were challenged with the periodontal
pathogen P. intermedia strain 17 as compared to wild-type P. gingivalis.
Points represent mean 6 SEM. Two-way ANOVA with Bonferroni’s post-
test was used for the statistical evaluation (*** p,0.001, **** p,0.0001).
doi:10.1371/journal.ppat.1003627.g002
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describing a case of joint pain that was successfully treated by tooth
extraction [12]. Within the last 20 years, this correlation has been
strengthened clinically and epidemiologically but the mechanistic
link between periodontitis and RA has remained elusive. Now, there
is an increasing body of evidence that severity of periodontitis is not
only related to progression of RA, but also that the profile of oral
microbiota in patients with new onset RA is extremely similar to that
in patients suffering from chronic RA [28,29]. Here, for the first
time, we demonstrate that infection with P. gingivalis not only
exacerbates CIA but also appears to play a role in sensitizing animals
to early disease development. The arthritis that occurred in mice
infected with P. gingivalis was characterized by significantly greater
bone and cartilage destruction in the affected joints. These clinical
signs of arthritis manifested significantly earlier and were accompa-
nied by a more severe disease course than in non-infected animals.
Moreover, aggravation of these RA-associated pathologies was
shown to be dependent on PPAD activity which either directly or
indirectly via enhancement of inflammatory reaction and release of
host PADs leads to generation of citrullinated neo-epitopes.
Regardless of the mechanism the presented data implicates that
PPAD, which among prokaryotes is unique to P. gingivalis, is a
possible trigger of a pathogenic autoimmune response leading to RA
development or at least may aggravate the course of the disease.
Both humoral and cellular immune responses have been shown
to contribute to the pathogenesis of PD and RA. Activated
neutrophils are primarily responsible for the characteristic tissue
Figure 3. Aggravation of collagen-induced arthritis in DBA/1 mice was dependent on the production of P. gingivalis
peptidylarginine deiminase (PPAD). Mice (n = 7) were inoculated with 16108 CFU P. gingivalis wild-type strain W83 or PPAD-knockout strain
(dPAD) and subsequently immunized with CII. (A) Kaplan-Meier plots displaying the clinical onset of arthritis (log-rank test, p = 0.002). (B) Mean
severity of arthritis in mice followed for 5–6 weeks after immunization. (C) Histological signs of synovitis and (D) erosion on day 45 after CII
immunization. (E) Scatter dot plot showing MPO activity in 1 g of joint tissue extract at day 45 after CII immunization. H&E staining of the
representative inflamed tarsal joints from (F) CII- immunized DBA/1, (G) mice infected with wild-type P. gingivalis strain W83, and (H) isogenic dPAD
mutant. Horizontal bar and error bars represent the mean and SEM, respectively. Statistical evaluation using two-way ANOVA with Bonferroni’s post-
test were employed for data in (B) and statistical differences between groups were analyzed using Mann-Whitney U test (C) or one way ANOVA (D).
** denotes p,0.01; ***, p,0.001; ****, p,0.0001.
doi:10.1371/journal.ppat.1003627.g003
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damage through the release of deleterious proteinases and pro-
inflammatory cytokines [30]. Consistent with those observations,
we found that neutrophil influx, as measured by MPO activity in
tissue homogenates, was significantly higher in the affected joints
of animals inoculated with P. gingivalis. It is important to mention
that neutrophil presence was not a consequence of bacteremia, as
the use of a variety of detection methods, including PCR-based
techniques, failed to detect any bacteria in the joints of infected
mice throughout the course of the experiment.
The early onset and aggravated progression of CIA occurred
only in animals inoculated with viable P. gingivalis. Infection with P.
intermedia, another important pathogen associated with periodontal
diseases [31], exerted no effect on the course of CIA. Significantly,
there were no observed differences in survival of P. intermedia and P.
gingivalis in the subcutaneous chambers. Nevertheless, it cannot be
excluded that P. intermedia fail to aggravate CIA because it elicited
a weaker host inflammatory response as compared to P. gingivalis.
Similar to infection with P. intermedia, inoculation with either heat-
killed P. gingivalis or purified cell-envelope fraction from the same
organism had no effect on either the rate or progression of CIA.
Therefore, we hypothesized that the requirement for live P.
gingivalis must be associated with active bacterial component(s)
exerting a direct effect on the host that ultimately triggered an
autoimmune reaction. This hypothesis also drew on the recent
findings in which immunity to P. gingivalis, but not to P. intermedia
(or Fusobacterium nucleatum), was shown to be significantly associated
with the presence of RA-related autoantibodies in individuals at
risk for the disease [32].
An increasing number of studies have pointed to post-
translational modifications as one of the main factors in the ability
of pathogens to breach immune tolerance [33–35]. Among these
modifications, citrullination of endogenous proteins seems to be a
key process in the initiation of autoimmune reactions [3,36].
Citrullination normally plays a pivotal role in the formation of
myelin and is crucial for normal structure of hair and skin. In
humans, five PADs (PAD1–PAD4 and PAD6) are variably
expressed in different tissues and these enzymes mediate deimina-
tion of Arg residues within proteins in a calcium-dependent
manner [37]. However, aberrant citrullination has been observed
in autoimmune diseases, among which, RA is a prime example
[38]. It is unclear, however, whether citrullination in RA creates
novel epitopes or uncovers cryptic ones in susceptible individuals.
The potential autoantigens in RA that are efficiently citrullinated
by human PADs include enolase, fibrinogen, vimentin, and CII
[39–41].
Through its unique expression of PAD, P. gingivalis is the only
prokaryote that is able to citrullinate proteins [42]. Not only is
PPAD able to citrullinate the cell-envelope proteins of P. gingivalis,
it also had been shown to modify host proteins in vitro [18]. The
enzyme seems to also be immunogenic in mice as we were able to
detect some antibodies against PPAD in animals inoculated with
wild type strain W83. Nevertheless, it is unlikely that this response
contributes to aggravation of CIA by P. gingivalis because the level
of anti-PPAD antibodies was very low. Unlike human PAD, PPAD
can efficiently modify C-terminal arginine and its activity is
calcium-independent, which enables protein modification even in
environments with low calcium concentrations. In our experi-
ments, the inoculation of animals with either a highly citrullinated
cell-envelope fraction or heat-killed bacteria carrying citrullinated
proteins on their surface did not alter CIA development and
progression. Therefore, we assume that PPAD generates non-self
epitopes, specifically C-terminal citrulline residues on host proteins
cleaved at Arg-Xaa peptide bonds by gingipains [18] and thereby
contributes to CIA pathology. To test this hypothesis, an isogenic
P. gingivalis-PAD knockout strain (dPAD) was created. Inoculation
of animals with dPAD prior to immunization with CII had no
influence on clinical CIA development and progression. Impor-
tantly, there was no significant difference in survival of the dPAD
mutant and the parental wild-type strain within implanted
chambers, in correlation with the same rate of growth in vitro of
both strains (Fig. S2). Histologically, dPAD inoculation had no
effect on the degree of synovitis, erosions, or neutrophil influx into
the joints as compared to CIA controls. This is in complete
contrast to animals infected with the live W83 strain, highlighting
the fact that PPAD probably contributes significantly towards the
pathogenesis of the disease.
Antibodies against citrullinated proteins are known to be a
specific marker for RA [43,44] and can be detected years before
the onset of the disease. In addition, their presence and serum
levels correlate strongly with disease severity [45]. Importantly, in
humans, PD in non-smoking untreated RA patients is associated
with high titers of antibodies against citrullinated proteins (aCCP)
[46]. Nevertheless, the role and/or the presence of aCCP
antibodies in CIA is highly controversial. Meaningfully, however,
our results showed a significant increase in aCCP antibody titers
only in the serum of animals infected with the parental P. gingivalis
Figure 4. Aggravation of collagen-induced arthritis in DBA/1
mice was dependent on the production of P. gingivalis
peptidylarginine deiminase (PPAD). (A) Development of arthritis
in DBA/1 mice (n = 7) inoculated with P. gingivalis wild-type W83 strain
or a PPAD-complemented mutant (dPAD+). Mean severity of arthritis in
mice followed for 5–6 weeks after immunization. B) Serum levels of IgG
antibodies against CII were determined by ELISA on day 45 after
immunization. Horizontal bar and error bars represent the mean and
SEM, respectively. Statistical evaluation using two-way ANOVA with
Bonferroni’s post-test (* p,0.05, ** p,0.01).
doi:10.1371/journal.ppat.1003627.g004
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strain W83, whereas animals inoculated with isogenic dPAD, heat-
killed bacteria, or cell-envelope fraction, aCCP antibodies
remained at similar levels to the CIA controls. Significantly, the
increase in aCCP antibodies was associated with high concentra-
tions of citrullinated proteins in the chamber fluid of mice infected
with strain W83 and correlated with increased level of antibodies
specific for human enolase-derived citrillinated epitope (CEP-1)
which cross-reacts with the equivalent epitope of P. gingivalis-
derived enolase. This bacterial epitope was implicated in induction
of autoimmune reaction in RA [41].
It should be kept in mind the essential differences in citrullinated
antigenic epitopes generated by endogenous PADs and PPAD. In
particular, P. gingivalis citrullination of surface proteins is depen-
dent on the action of Arg-gingipains proteases expressed in
abundance by the organism since Arg-gingipain-null mutants are
devoid of citrullination. This concerted action facilitated by co-
localization of both enzymes in the outer membrane also targets
host proteins to generate polypeptides with citrullinated Arg
located at the C-termini. Antibodies against such epitopes may not
recognized internal citrullines generated by PADs and vice versa,
but they may still bind to CCP system with sequences optimized to
detect a wide range of host antibodies against different
citrullinated epitopes. Although we were not able to specifically
identify the modified proteins, high levels of citrullinated proteins
in the chamber fluid suggests that PPAD contributes, at least
partially, to the characteristic intensive citrullination of proteins in
the periodontal stroma in PD [47]. Together, it is tempting to
hypothesize host proteins citrullinated by PPAD-producing P.
gingivalis may contribute to a breach of immune tolerance in
susceptible individuals that subsequently triggers an inappropriate
immune response that exacerbates CIA. This knowledge may
create new perspectives in the treatment and prevention of RA.
Materials and Methods
Mice
Animal experiments were performed on 6- to 8-weeks old male
DBA/1 mice that were obtained from Medical College of
Jagiellonian University and Taconic (Europe A/S, Ry, Denmark),
respectively.
Bacterial strains
Porphyromonas gingivalis strain W83 and Prevotela intermedia strain
17 were grown on blood agar plates in an anaerobic chamber with
85% N2, 5% H2 and 10% CO2. Isogenic PPAD-knockout strain
(dPAD) of P. gingivalis W83 and complement mutant (dPAD+)
[18] were grown under the same conditions with the addition of
erythromycin at a concentration of 5 mg/ml. After incubation at
37uC for 5 days, bacterial cells were inoculated into enriched
Schoedler broth (Becton Dickinson), supplemented with hemin
(5 mg/ml) and menadione (0.5 mg/ml) and grown overnight in
anaerobic conditions.
Prior to inoculation, bacteria were washed three times with
phosphate-buffered saline (PBS) and resuspended in fresh culture
medium. Bacterial cell counts were determined using a spectro-
photometer, where the optical density of 1.0 at 600 nm
corresponded to 16109 CFU per/ml.
Experimental protocols of in vivo studies
Two separate sets of experiments regarding impact of P.
gingivalis and citrullination were conducted. To elucidate impor-
tance of live bacteria, subcutaneous chamber model was employed
in our experiments as an established P. gingivalis infection model
that creates a niche inside hosts for bacterial colonization [17]. To
this end titanium wire coils (10 mm65 mm) were implanted
Figure 5. Inoculation with P. gingivalis strain W83 leads to citrullination in vivo and, in turn, production of antibody against
citrullinated proteins (aCCP). (A) Subcutaneously implanted titanium chambers were inoculated with: 1) 16108 P. gingivalis, 2) PBS, 3) 56107 and
4) 16107 P. gingivalis. After 24 h, 20 ml of chamber fluid was collected and assayed for citrullinated proteins by immunoblotting with anti-modified
citrulline antibody. B) Level of citrullinated proteins in chamber fluid 7 days post-inoculation. Pooled chamber fluid from 2 independent experiments
was used. Horizontal bar and error bars represent the mean and SEM, respectively. C) Serum titers of aCCP IgG and D) IgG antibodies against CEP-1
were determined using an ELISA 45 days post-immunization with CII. Error bars represent the SEM. Statistical evaluation was carried out using one
way ANOVA. * denotes p,0.05.
doi:10.1371/journal.ppat.1003627.g005
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subcutaneously in the dorso-lumbar region of each mouse
following anesthesia. Incisions were closed using 4.0 G silk sutures
and the animals were allowed to rest for 14 days to heal completely
to allow for the formation of a fibrous capsule surrounding the
coils, thereby, creating chambers into which bacteria or cell-
envelope of P. gingivalis could be inoculated. We employed this
model instead oral gavage model (oral infection) because mice are
not natural host for P. gingivalis. Further, the CIA model requires
use of DBA/1 animals, which are resistant to P. gingivalis
colonization after oral challenge. We have performed a few trial
experiments using live P. gingivalis (W83 strain) in the oral infection
model but we were not able to detect viable P. gingivalis after 24 h
post-challenge. CII immunization was performed 14 days after
bacteria inoculation. To study the influence of auto-citrullinated
proteins of P. gingivalis, mice were immunized with 50 mg of the cell
envelope fraction 2 weeks prior to CIA.
Chamber inoculation with P. gingivalis
DBA/1 mice were divided into experimental groups of at least 7
mice and each animal was implanted with a coiled wire chamber
at the dorsolateral aspect. Animals were allowed to recover from
the surgical procedure for 14 days prior to being challenged with
bacteria. Bacteria were inoculated with 108 CFU (0.1 ml at
109 CFU/ml) into the lumen of the sealed chamber with a 25-G
needle through the disinfected skin. Sterilized 0.1 mL of the same
culture medium was used to sham inject the control chambers.
The course of infection was monitored clinically. Two weeks after
chamber injection with P. gingivalis, mice were immunized with CII
CIA
Immunization and arthritis evaluation was performed as
described [48] with modification. DBA/1 mice were injected i.d.
at the base of the tail with 100 mg CII (Chondrex) in CFA. Booster
immunization containing 100 mg of CII in IFA was administered
21 days after the priming.
Clinical evaluation of arthritis
All DBA/1 mice were inspected at regular intervals to ascertain
the presence of arthritis. To evaluate the intensity of arthritis, a
clinical scoring system of 0–4 points for each paw was used: 0, no
sign of inflammation; 1, mild swelling and/or erythema; 2,
moderate swelling and erythema; 3, marked swelling and
erythema; 4, extreme erythema and swelling. Clinical index was
constructed by adding the scores from all four limbs for each
animal.
Histological examination
All four paws from DBA/1 mice in the first experiment were
excised at the termination of the experiment (45 days after CII
immunization). Tissue sections were stained with hematoxylin/
eosin and synovitis and erosion of bone/cartilage were evaluated
by a blinded examiner. A histological scoring system was used as
follows: 1, mild; 2, moderate; and 3, severe synovitis and joint
damage. Knee joints, ankles, elbows, and wrists were inspected,
and a mean score from all of the inspected paws in each animal
was calculated.
Purification of P. gingivalis cell envelope
Bacterial cells were collected from culture medium by centri-
fugation, resuspended in 50 mM N-(2-hydroxyethyl) piperazine-
N9-(2-ethanesulphonic acid), pH 7.0, and sonicated in an ice bath
at 1500 Hz for five 1 minute cycles (Sonics and Materials).
Unbroken cells and large debris were removed by centrifugation
and the cloudy supernatant was clarified by ultracentrifugation
(32,5006 g, 60 min, 4uC). The resulting clear supernatant was
regarded as the membrane-free cell extract. The pellet containing
the outer membrane, peptidoglycan and the inner membrane was
resuspended in the same buffer and referred to as cell envelope
fraction.
Detection of citrullinated proteins in the chamber fluid
Up to 50 ml of chamber fluid was aspirated on day 1 after
inoculation and centrifuged to remove bacteria. Citrullinated
proteins were detected using an anti-citrulline (modified) detection
kit (Upstate/Millipore) in accordance with the manufacturer’s
instructions.
Measurements of aPPAD antibodies in mouse sera
CEP-1 was diluted at 10 mg/ml in coating buffer (50 mM
carbonate buffer, pH 9.5), and PPAD was diluted at 5 mg/ml in
coating buffer. Costar 96-well ELISA plates were coated with
50 ml/well antigen solution and incubated overnight at 4uC. Wells
were washed 46with PBS-Tween (0.05%) and blocked with 2%
BSA in PBS for 5 hours at room temperature. Mouse serum was
diluted 1:50 in RIA buffer (1% (w/v) BSA, 350 mM NaCl,
10 mM Tris-HCl (pH 7.6), 1% (v/v) Triton X-100, 0.5% (w/v)
Na-deoxycholate, 0.1% (w/v) SDS), added in duplicates, and
incubated overnight at 4uC. Plates were washed as described
above and incubated with peroxidase-conjugated rabbit anti-
mouse IgG (Dako) (1:5000) in RIA-buffer for 1.5 hours at room
temperature. After a final wash, bound antibodies were detected
with tetramethylbenzidine substrate (TMB) (KPL, Gaithersburg,
MD). The reaction was stopped after 5 minutes by the addition of
1M H2SO4 and absorbance measured at 450 nm. All OD values
are given following the subtraction of background for each plate
(coating buffer alone). When the subtracted values were less than
zero, a value of zero was given to the respective sample.
Determination of P. gingivalis presence in inflamed joints
To verify the presence or absence of P. gingivalis in the inflamed
joint tissue we have employed a standard cultivation method and
PCR to specifically amplify 16S RNA of P. gingivalis. The forward
(sense) primer 59-CGTGCCAGCAGCCGCGGTAATACG-39
and the reverse (antisense) primer 59-TACATAGAAGCCCC-
GAAGGAAGAC-39) were used. PCR amplification was carried
out using the following conditions: 40 cycles of denaturation at
95uC for 30 sec, annealing at 60uC for 30 sec, and elongation at
72uC for 1 min. The PCR products were separated by agarose gel
electrophoresis and visualized.
Determination of joint myeloperoxidase (MPO) content
Joint tissues were homogenized in 0.5% hexadecyltrimethylam-
monium bromide pH 6.0 (50 mg of tissue/ml). The homogenates
were freeze – thawed 3 times, centrifuged at 40,0006g and 0.1 ml
aliquots were mixed with 2.9 ml phosphate buffer (pH = 6.0)
containing H2O2 and 0.167 mg/ml o-dianisidine dihydrochloride
(Sigma Aldrich). Absorbance was measured at 460 nm. MPO
activity was expressed in units per protein concentration (U/g of
protein).
Determination of citrulline content and PPAD activity in
chamber fluid
The presence of citrulline was determined using the modified
Boyde and Rahmatullah method [49], based on the chemical
modification of citrulline side-chains and colorimetric detection of
their derivatives. Briefly, 1 ml of chamber fluid was diluted with
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9 ml of PBS and mixed with 0.1 M Tris, 5 mM DTT in a 96-well
followed by 10 ml of 5 M HClO4. The reaction was developed by
the addition of 150 ml freshly prepared 1:2 mixture of solution A
(0.5% diacetyl monoxime, 0.01% thiosemicarbazide in water) and
B (0.25 mg/ml FeCl3, 24.5% H2SO4, 17% H3PO4 in water).
The plates were incubated at 110uC for 17 minutes. Color
development was measured using a SpectraMax microplate
absorbance reader (Molecular Devices, CA, USA) at 535 nm.
Quantity of citrulline in the samples was calculated via a standard
curve using free L-citrulline.
Measurement of serum anti-CII, anti CEP-1 and anti-
citrullinated peptide (aCCP) antibody levels
Serum samples were collected on day 45 post-immunization
and level of CII-specific IgG was measured using a mouse anti-
type II collagen IgG assay kit. Levels of aCCP in sera were
measured using Immunoscan RA Anti-CCP Test Kit with
modifications. Peroxidase-conjugated rabbit anti-mouse IgG
specific for gamma chains antibodies were used for detection
(Dako A7S, Denmark).
Statistical analysis
Statistical comparison analyses were performed using GraphPad
Prism (GraphPad, San Diego, CA). All results presented in the text
are means 6 standard error of the means. Differences between 2
groups were tested for statistical significance using Mann-Whitney
U test and the log-rank test was used for comparing Kaplan-Meier
curves. 2-way ANOVA and one way ANOVA with Bonferroni
posttest were used for comparison of multiple groups. A p value of
,.05 was considered statistically significant
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Supporting Information
Figure S1 Serum levels of IgG antibodies against PPAD were
quantified with ELISA on day 45 post-immunization. Horizontal
bar and error bars represent the mean and SEM, respectively.
(TIF)
Figure S2 Comparison of the growth curves of P. gingivalis wild
type W83 and its isogenic dPAD mutant. Cells were grown in TSB
medium. Representative growth curves are shown. One-milliliter
aliquots were taken, and cell density at OD 600 nm was measured
over a 36 h period.
(TIF)
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